2006
DOI: 10.4049/jimmunol.177.5.3260
|View full text |Cite
|
Sign up to set email alerts
|

Bone Marrow Stromal Cell Antigen 2 Is a Specific Marker of Type I IFN-Producing Cells in the Naive Mouse, but a Promiscuous Cell Surface Antigen following IFN Stimulation

Abstract: Type I IFN-producing cells (IPC) are sentinels of viral infections. Identification and functional characterization of these cells have been difficult because of their small numbers in blood and tissues and their complex cell surface phenotype. To overcome this problem in mice, mAbs recognizing IPC-specific cell surface molecules have been generated. In this study, we report the identification of new Abs specific for mouse IPC, which recognize the bone marrow stromal cell Ag 2 (BST2). Interestingly, previously … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

28
434
1
1

Year Published

2008
2008
2020
2020

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 383 publications
(464 citation statements)
references
References 33 publications
28
434
1
1
Order By: Relevance
“…71,72 Notably, the specificity of BST-2 as a pDC marker was recently challenged, because BST-2 is inducible by interferon (IFN)-g treatment on other cells, including T cells, B cells and plasma cells. 70 The second pDC-restricted surface marker is Siglec-H, which is recognized by the 440C antibody that blocks type I IFN production by pDC, but does not induce depletion. 73 In contrast to the bulk of cDCs, pDCs are rather longlived and estimated to have an average lifespan of about 2 weeks.…”
Section: Pathogen Defensementioning
confidence: 99%
“…71,72 Notably, the specificity of BST-2 as a pDC marker was recently challenged, because BST-2 is inducible by interferon (IFN)-g treatment on other cells, including T cells, B cells and plasma cells. 70 The second pDC-restricted surface marker is Siglec-H, which is recognized by the 440C antibody that blocks type I IFN production by pDC, but does not induce depletion. 73 In contrast to the bulk of cDCs, pDCs are rather longlived and estimated to have an average lifespan of about 2 weeks.…”
Section: Pathogen Defensementioning
confidence: 99%
“…These two populations show a high degree of similarity with respect to function, development, and gene expression, and for simplicity will be grouped together and further referred to as CD4 + cDCs in this review [9]. A fourth population of plasmacytoid DCs (pDC) is defined by the expression of several distinguishing markers including B220, Siglec-H, and Bst2 [10][11][12]. Human counterparts for each of these DC subtypes have been identified, underscoring the conservation of DC lineage diversification across species, presumably owing to their important functional specialization [13][14][15].…”
Section: Unique Functions and Subsets Of DC Lineagesmentioning
confidence: 99%
“…The role of Tregs in a tumor microenvironment can be translated into anergy and immunosuppression, favoring the immune escape of tumor cells with the concomitant increase of tumor burden (14,22). To evaluate whether pDCs were crucial for tumor outgrowth after LPS treatment, we depleted pDCs using a pDC depleting Ab (m927 Ab) (14,23). m927 Ab or IgG control was injected the same day as LPS administration and every 2 d before mice were sacrificed on day 14 (7 d after LPS injection) (Fig.…”
Section: Low-dose Lps Facilitates An Immunosuppressive Environment Inmentioning
confidence: 99%